Literature DB >> 10837221

Regulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinase.

S Kharbanda1, V Kumar, S Dhar, P Pandey, C Chen, P Majumder, Z M Yuan, Y Whang, W Strauss, T K Pandita, D Weaver, D Kufe.   

Abstract

BACKGROUND: Telomeres consist of repetitive (TTAGGG) DNA sequences that are maintained by the multisubunit telomerase ribonucleoprotein. Telomerase consists of an RNA, which serves as template for the sequence tracts, and a catalytic subunit that functions in reverse transcription of the RNA template. Cloning and characterization of the human catalytic subunit of telomerase (hTERT) has supported a role in cell transformation. How telomerase activity is regulated, however, is largely unknown.
RESULTS: We show here that hTERT associates directly with the c-Abl protein tyrosine kinase. We also found that c-Abl phosphorylates hTERT and inhibits hTERT activity. Moreover, our findings demonstrate that exposure of cells to ionizing radiation induces tyrosine phosphorylation of hTERT by a c-Abl-dependent mechanism. The functional significance of the c-Abl-hTERT interaction is supported by the demonstration that cells deficient in c-Abl show telomere lengthening.
CONCLUSIONS: The ubiquitously expressed c-Abl tyrosine kinase is activated by DNA double-strand breaks. Our finding of telomere lengthening in c-Abl-deficient cells and the functional interactions between c-Abl and hTERT support a role for c-Abl in the regulation of telomerase function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10837221     DOI: 10.1016/s0960-9822(00)00483-8

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  40 in total

Review 1.  Natural and pharmacological regulation of telomerase.

Authors:  Jean-Louis Mergny; Jean-François Riou; Patrick Mailliet; Marie-Paule Teulade-Fichou; Eric Gilson
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

Review 2.  Complex regulation of telomerase activity: implications for cancer therapy.

Authors:  K S Elenitoba-Johnson
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

Review 3.  Tiptoeing to chromosome tips: facts, promises and perils of today's human telomere biology.

Authors:  J Fajkus; M Simícková; J Maláska
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-04-29       Impact factor: 6.237

4.  Function, replication and structure of the mammalian telomere.

Authors:  Dominique Broccoli
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

5.  Protein kinase C delta (PKCδ) splice variant modulates senescence via hTERT in adipose-derived stem cells.

Authors:  Gay Carter; Rekha Patel; André Apostolatos; Michel Murr; Denise R Cooper; Niketa A Patel
Journal:  Stem Cell Investig       Date:  2014-01-19

6.  Genetic Variations in Telomere Maintenance, with Implications on Tissue Renewal Capacity and Chronic Disease Pathologies.

Authors:  M A Trudeau; J M Y Wong
Journal:  Curr Pharmacogenomics Person Med       Date:  2010-03-01

7.  Disruption of Survivin in K562 cells elevates telomerase activity and protects cells against apoptosis induced by the Bcr-abl kinase inhibitor STI571.

Authors:  Zhanxiang Wang; Louis M Pelus
Journal:  Cancer Ther       Date:  2008

Review 8.  Human telomerase and its regulation.

Authors:  Yu-Sheng Cong; Woodring E Wright; Jerry W Shay
Journal:  Microbiol Mol Biol Rev       Date:  2002-09       Impact factor: 11.056

Review 9.  Telomeres, histone code, and DNA damage response.

Authors:  S Misri; S Pandita; R Kumar; T K Pandita
Journal:  Cytogenet Genome Res       Date:  2009-01-30       Impact factor: 1.636

10.  Nuclear protein tyrosine phosphatase Shp-2 is one important negative regulator of nuclear export of telomerase reverse transcriptase.

Authors:  Sascha Jakob; Peter Schroeder; Margarete Lukosz; Nicole Büchner; Ioakim Spyridopoulos; Joachim Altschmied; Judith Haendeler
Journal:  J Biol Chem       Date:  2008-10-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.